4896.T
Price:
$640
Market Cap:
$7.43B
K Pharma,Inc. engages in the research, development, manufacture, and sale of regenerative medicines and pharmaceutical products in Japan. It develops regenerative medicine products using disease-specific induced pluripotent stem (iPS) cell technology for spinal cord injuries and cerebral infarctions. The company was incorporated in 2016 and is based in Minato, Japan.
Industry
Biotechnology
IPO Date
2023-10-17
Stock Exchange
JPX
Ticker
4896.T
According to K Pharma,Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -8.59. This represents a change of -13.73% compared to the average of -9.96 of the last 4 quarters.
The mean historical PE Ratio of K Pharma,Inc. over the last ten years is -11.70. The current -8.59 PE Ratio has changed 7.24% with respect to the historical average. Over the past ten years (40 quarters), 4896.T's PE Ratio was at its highest in in the June 2023 quarter at 0. The PE Ratio was at its lowest in in the September 2023 quarter at -23.48.
Average
-11.70
Median
-15.52
Minimum
-47.86
Maximum
32.10
Discovering the peaks and valleys of K Pharma,Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual PE Ratio = 32.10
Minimum Annual Increase = -242.54%
Minimum Annual PE Ratio = -47.86
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -8.51 | -126.53% |
| 2023 | 32.10 | -242.54% |
| 2022 | -22.52 | -52.95% |
The current PE Ratio of K Pharma,Inc. (4896.T) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
0.35
5-year avg
-11.70
10-year avg
-11.70
K Pharma,Inc.’s PE Ratio is less than OncoTherapy Science, Inc. (-7.06), greater than Noile-Immune Biotech Inc. (-10.07), less than ADR120S, Inc. (-4.07), less than BrightPath Biotherapeutics Co., Ltd. (-4.40), less than TMS Co., Ltd. (-8.13), greater than Linical Co., Ltd. (-10.76), less than Chiome Bioscience Inc. (-7.56), less than Kohjin Bio Co., Ltd. (11.15), less than MEDINET Co., Ltd. (-5.71), less than MedRx Co., Ltd (-4.39),
| Company | PE Ratio | Market cap |
|---|---|---|
| -7.06 | $7.11B | |
| -10.07 | $6.97B | |
| -4.07 | $7.44B | |
| -4.40 | $4.63B | |
| -8.13 | $6.10B | |
| -10.76 | $6.82B | |
| -7.56 | $7.55B | |
| 11.15 | $7.96B | |
| -5.71 | $8.21B | |
| -4.39 | $6.53B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like K Pharma,Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like K Pharma,Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is K Pharma,Inc.'s PE Ratio?
How is the PE Ratio calculated for K Pharma,Inc. (4896.T)?
What is the highest PE Ratio for K Pharma,Inc. (4896.T)?
What is the 3-year average PE Ratio for K Pharma,Inc. (4896.T)?
What is the 5-year average PE Ratio for K Pharma,Inc. (4896.T)?
How does the current PE Ratio for K Pharma,Inc. (4896.T) compare to its historical average?